Based on results from trials in people with sleep apnea, the company said it plans to submit the material to the US Food and Drug Administration to potentially expand the use of Zepbound for obstructive sleep apnea. Obstructive sleep apnea is a disorder that causes people to briefly stop breathing while they are sleeping, sometimes several times an hour.
One study looked at the effect of the drug on people who were both unwilling or unable to use positive airway pressure therapy, a machine that will pump pressurized air into a person’s airway to keep it open and prevent breathing problems while they sleep. People who use the machine must wear a mask or use a nosepiece and some people find it difficult to sleep with the device. The other study looked at a group who used or planned to continue to use the PAP machine.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company saysBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Costco Offers Weight Loss Program with Medications from Eli Lilly and Novo NordiskCostco partners with Sesame to provide a weight loss program to members, offering medications like Ozempic and Wegovy. Members can receive three months of clinical consultation and other services for $179.
Source: FoxBusiness - 🏆 458. / 53 Read more »
Eli Lilly warns 2 of its insulin products may be out of stockThe shortage applies to the company's 10 mL vials of Humalog and Insulin Lispro Injection medications.
Source: 10News - 🏆 732. / 50 Read more »
Eli Lilly Warns That 2 Insulin Products Will Be in Short SupplyDrugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products.
Source: MedicineNet - 🏆 575. / 51 Read more »
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughtsThe review examined several drugs from Novo Nordisk, including Wegovy, Ozempic, Rybelsus, and Saxenda, but did not include Eli Lilly’s Zepbound and…
Source: NBCDFW - 🏆 288. / 63 Read more »
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughtsThe review examined several drugs from Novo Nordisk, including Wegovy, Ozempic, Rybelsus, and Saxenda, but did not include Eli Lilly’s Zepbound and…
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »